VistaGen Therapeutics
VTGN
VTGN
17 hedge funds and large institutions have $3.8M invested in VistaGen Therapeutics in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$438K | |
| 2 | +$112K | |
| 3 | +$29.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$16K |
| 5 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
+$2K |
Top Sellers
| 1 | -$99K | |
| 2 | -$62K | |
| 3 | -$32K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$22K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$21K |